Member Info for tqhussain

Gold $2400+

Looks like it’s going to happen this time around.

Https://www.linkedin.com/feed/update/urn:li:activity:7182388338216042496?updateEntityUrn=urn%3Ali%3Afs_feedUpdate%3A%28V2%2Curn%3Ali%3Aactivity%3A7182388338216042496%29

Https://www.onearabia.me/global/genincode-cardio-incode-score-chd-risk-assessment-011-20083.html

Nice update and a good platform for the share price to build on.

Yup

Lipid, ROCA and soon (fingers crossed) CIC.

The future looks bright!

I couldn’t find it on there.

I am confident it will be a positive outcome and articles like the one below help understand why.

https://www.sciencedirect.com/science/article/pii/S2666667724000291#tbl0002

Is in the mix.

“Some tests continue to be done on the coking coal reserves in Binga and Hwange areas”

https://www.herald.co.zw/open-for-business-policy-bears-fruit-as-global-steel-giant-imports-us10m-coke-from-hwange-monthly/amp/

This was to your question Superda.

A lot hinges on the FDA approval of CIC.

A lot hinges on the FDA approval of CIC.

Lipid test generated £950K in 6 months with sales mainly from Spain. Now we have nhs on board plus the USA market soon.

Highly recommend new investors read the last interim report. You will get a good idea of what's coming up and also well the company has done in getting products to market.

The problem:

https://www.cancerresearchuk.org/about-cancer/ovarian-cancer/getting-diagnosed/screening

And now the solution:

https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-study-of-a-test-called-roca-for-women-who-have-a-high-risk-of-developing-ovarian-cancer-aldo#undefined

MC is soo low.

Lipid testing is a go and generating sales.

ROCA is now a go.

Cardio fda approval due in the coming weeks.

Roughly £4m cash

Roughly £1m revenue in the last interims

I like this line 'recommendation as the preferred test'

announces that its Risk of Ovarian Cancer Algorithm ("ROCA") test, has received a National Institute for Health and Care Excellence ("NICE") recommendation as the preferred test for OC surveillance in individuals at high risk of ovarian cancer who do not undertake risk reducing surgery.

Great news!

FDA for Cardio test yet to come which will be the big one.

Gold @ 2206 - This should help THX present great number $$.

If they can hit revenue of £2m for year end, I would be quite happy with that.

Makes sense, thanks for the info!